Improving and Accelerating Therapeutic Development for Nervous System Disorders
Publisher: National Academies Press 2013
Number of pages: 116
The aim was to examine opportunities to accelerate early phases of drug development for nervous system drug discovery. Workshop participants discussed challenges in neuroscience research for enabling faster entry of potential treatments into first-in-human trials, explored how new and emerging tools and technologies may improve the efficiency of research, and considered mechanisms to facilitate a more effective and efficient development pipeline.
Home page url
Download or read it online for free here:
by Holger Stark - De Gruyter Open Ltd
The histamine H4 receptor is the most recently detected histamine receptor subtype. The molecular signaling mechanism and localization of the receptor will be described together with its influence on physiological and pathophysiological properties.
- International Agency for Research on Cancer
This volume provides an assessment of the carcinogenicity of 14 drugs and herbal products. The authors relied on epidemiological studies to evaluate the carcinogenic hazard to humans exposed to the drugs digoxin, pioglitazone and hydrochlorothiazide.
by Kenneth L Davis, at al. - Lippincott Williams & Wilkins
This book establishes a critical bridge connecting new discoveries in molecular and cellular biology, genetics, and neuroimaging with the etiology, diagnosis, and treatment of the full spectrum of neuropsychiatric disorders.
- U.S. Department of Health and Human Services
The publication, Approved Drug Products (commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act.